Intracoronary delivery of injectable bioabsorbable scaffold (IK-5001) to treat left ventricular remodeling after ST-elevation myocardial infarction: a first-in-man study. [electronic resource]
Producer: 20150827Description: 806-12 p. digitalISSN:- 1941-7632
- Absorbable Implants -- adverse effects
- Adult
- Aged
- Alginates -- administration & dosage
- Belgium
- Calcium Gluconate -- administration & dosage
- Feasibility Studies
- Female
- Germany
- Glucuronic Acid -- administration & dosage
- Heart Function Tests
- Hexuronic Acids -- administration & dosage
- Humans
- Hydrogels
- Injections, Intra-Arterial
- Male
- Middle Aged
- Myocardial Infarction -- diagnosis
- Pilot Projects
- Predictive Value of Tests
- Regenerative Medicine -- methods
- Surveys and Questionnaires
- Time Factors
- Tissue Engineering -- methods
- Tissue Scaffolds -- adverse effects
- Treatment Outcome
- Ventricular Dysfunction, Left -- diagnosis
- Ventricular Function, Left
- Ventricular Remodeling
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.